found that bufexamac suppressed neutrophil chemotaxis and ameliorated lung injury by directly inhibiting the LTA4H enzymatic reaction, resulting in reduced LTB4 levels in LPS-induced ALI (34). This evidence concerns the gene LTA4H and acute respiratory distress syndrome.